Cardiovascular risk factors, comorbidity, and survival outcomes in black and white dialysis patients

被引：14

作者：

Furth, S ^{[1
]}

Hermann, JA ^{[1
]}

Powe, NR ^{[1
]}

机构：

[1] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA

来源：

SEMINARS IN DIALYSIS | 1998年 / 11卷 / 02期

关键词：

D O I：

10.1111/j.1525-139X.1998.tb00310.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：102 / 105

页数：4

共 8 条

[1]

[Anonymous], 1991, Kidney failure and the federal government. Committee for the Study of the Medicare End-Stage Renal Disease Program

[2] CANADIAN HEMODIALYSIS MORBIDITY STUDY [J].

CHURCHILL, DN ;

TAYLOR, DW ;

COOK, RJ ;

LAPLANTE, P ;

BARRE, P ;

CARTIER, P ;

FAY, WP ;

GOLDSTEIN, MB ;

JINDAL, K ;

MANDIN, H ;

MCKENZIE, JK ;

MUIRHEAD, N ;

PARFREY, PS ;

POSEN, GA ;

SLAUGHTER, D ;

ULAN, RA ;

WERB, R .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) :214-234

[3] END-STAGE RENAL-DISEASE IN US MINORITY-GROUPS [J].

FELDMAN, HI ;

KLAG, MJ ;

CHIAPELLA, AP ;

WHELTON, PK .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (05) :397-410

[4] CARDIOVASCULAR CHANGES IN CHRONIC-HEMODIALYSIS PATIENTS [J].

IKRAM, H ;

LYNN, KL ;

BAILEY, RR ;

LITTLE, PJ .

KIDNEY INTERNATIONAL, 1983, 24 (03) :371-376

[5] OUTCOME OF CONGESTIVE HEART-FAILURE, DILATED CARDIOMYOPATHY, HYPERTROPHIC HYPERKINETIC DISEASE, AND ISCHEMIC-HEART-DISEASE IN DIALYSIS PATIENTS [J].

PARFREY, PS ;

GRIFFITHS, SM ;

HARNETT, JD ;

TAYLOR, R ;

KING, A ;

HAND, J ;

BARRE, PE .

AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (03) :213-221

[6] THE CLINICAL COURSE OF LEFT-VENTRICULAR HYPERTROPHY IN DIALYSIS PATIENTS [J].

PARFREY, PS ;

HARNETT, JD ;

GRIFFITHS, SM ;

TAYLOR, R ;

HAND, J ;

KING, A ;

BARRE, PE .

NEPHRON, 1990, 55 (02) :114-120

[7]

PARFREY PS, 1991, J AM SOC NEPHROL, V2, P2

[8]

*USRDS, 1997, USRDS 1997 ANN DAT R

← 1 →